Healthcare / Medical DevicesUpdated 2026-05-09 17:08 UTC

AXGN stock hub

Axogen, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AXGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AXGN

In the news

Latest news · AXGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E69.7

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-18

P25 -105.6P50 -46.5P75 -3.1

ROIC-2.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AXGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000805928
Company name	Axogen, Inc.
Country	United States
Country code	US
Cusip	05463X106
Employees	622
Employees Change	170%
Employees Change Percent	37.61
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US05463X1063
Last refreshed	2026-05-09
Market cap	$2.2B
Market cap category	Mid-Cap
Price	$42.06
Price currency	USD
Rev Per Employee	382,805.47x
Sector	Healthcare
Sic	3845
Symbol	AXGN
Website	https://www.axogeninc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.41%
EV Sales Forward	7.65x
EV/FCF	232.35x
EV/Sales	9.05x
FCF yield	0.41%
Forward P/E	69.7x
P/B ratio	9.13x
P/S ratio	9.39x
PS Forward	7.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.79%
EBITDA Margin	-0.9%
FCF margin	3.9%
Gross margin	75.01%
Gross Profit	$178.6M
Gross Profit Growth	23.78%
Gross Profit Growth Q	32.22%
Gross Profit Growth3 Y	14.99%
Gross Profit Growth5 Y	12.95%
Net Income	$-31.5M
Net Income Growth Years	0%
Pretax Margin	-13.21%
Profit Margin	-13.21%
Profit Per Employee	$-50,568
ROA	-2.32
Roa5y	-5.43
ROCE	-3.42
ROE	-17.96
Roe5y	-19.11
ROIC	-2.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.24%
Cagr1y	156.79%
Cagr3y	64.65%
Cagr5y	12.35%
EPS Growth Years	0
FCF Growth	680.32%
OCF Growth	329.49%
Revenue Growth	22.41x
Revenue Growth Q	26.56x
Revenue Growth Quarters	16x
Revenue Growth Years	15x
Revenue Growth3 Y	18.18x
Revenue Growth5 Y	14.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.98
Assets	$289.5M
Cash	$101.6M
Current Assets	$184.7M
Current Liabilities	$26M
Debt	$20.6M
Debt EBITDA	$9.41
Debt Equity	$0.08
Debt FCF	$2.22
Equity	$244.8M
Interest Coverage	-1.47
Liabilities	$44.7M
Long Term Assets	$104.8M
Long Term Liabilities	$18.7M
Net Cash	$81M
Net Cash By Market Cap	$3.62
Net Debt Equity	$-0.33
Net Debt FCF	$-8.73
Tangible Book Value	$237.5M
Tangible Book Value Per Share	$4.47
WACC	10.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.1
Inventory Turnover	1.46
Net Working Capital	$59.2M
Quick ratio	4.99
Working Capital	$158.7M
Working Capital Turnover	$2.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.47%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	644.43%
1Y total return	156.62%
200-day SMA	26.6
3Y total return	346.5%
50-day SMA	34.81
50-day SMA vs 200-day SMA	50over200
5Y total return	78.98%
All Time High	56.85
All Time High Change	-26.02%
All Time High Date	2018-07-24
All Time Low	2.05
All Time Low Change	1,951.71%
All Time Low Date	2011-10-04
ATR	2
Beta	1.17
Beta1y	2.02
Beta2y	1.08
Ch YTD	28.51
High	43.48
High52	45.83
High52 Date	2026-04-28
High52ch	-8.23%
Low	41.69
Low52	9.22
Low52 Date	2025-06-18
Low52ch	356.43%
Ma50ch	20.83%
Premarket Change Percent	1.27
Premarket Price	$43.96
Premarket Volume	267
Price vs 200-day SMA	58.14%
RSI	62.96
RSI Monthly	76.74
RSI Weekly	68.86
Sharpe ratio	1.8x
Sortino ratio	2.94
Total Return	-6.47%
Tr YTD	28.51
Tr1m	35.72%
Tr1w	-2.82%
Tr3m	20.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.07
Earnings Revenue Estimate	57,953,336x
Earnings Revenue Estimate Growth	19.34x
Operating Income	$-9M
Operating margin	-3.79
Price target	$42.33
Price Target Change	$0.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51,994,210%
Float Percent	97.77%
Net Borrowing	-48,623,000
Shares Insiders	2.23%
Shares Institutions	83.02%
Shares Out	53,177,824
Shares Qo Q	9.93%
Shares Yo Y	6.47%
Short Float	7.17%
Short Ratio	3.94
Short Shares	7.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.8M
Average Volume	1,175,961.2x
Bv Per Share	4.61
CAPEX	$-6.3M
Ch10y	644.4
Ch1m	35.72
Ch1w	-2.82
Ch1y	156.6
Ch3m	20.41
Ch3y	346.5
Ch5y	78.98
Ch6m	78.45
Change	-3.11%
Change From Open	-3.27
Close	43.41
Days Gap	0.16
Depreciation Amortization	6,885,000
Dollar Volume	23,765,077.7
Earnings Date	2026-04-28
Earnings Time	bmo
EBIT	$-9M
EBITDA	$-2.1M
EPS	$-0.67
F Score	4
FCF	$9.3M
FCF EV Yield	0.43x
FCF Per Share	$0.17
Financing CF	67,622,000
Fiscal Year End	December
Investing CF	-22,620,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	30.28
Ma150ch	38.89%
Ma20	39.52
Ma20ch	6.44%
Net CF	60,558,000
Next Earnings Date	2026-08-04
Open	43.48
Optionable	Yes
P FCF Ratio	241.1
P OCF Ratio	143.8
Position In Range	20.67
Post Close	42.06
Postmarket Change Percent	-1.93
Postmarket Price	$41.25
Ppne	97,318,000
Pre Close	43.41
Price Date	2026-05-08
Ptbv Ratio	9.42
Relative Volume	0.48x
Revenue	238,105,000x
SBC By Revenue	14.3x
Share Based Comp	34,046,000
Tr6m	78.45%
Us State	Florida
Volume	565,028
Z Score	13.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AXGN pay a dividend?

Capital-return profile for this ticker.

Performance

AXGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AXGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.0%

Float: +97.8% of shares outstanding

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AXGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.0

Neutral momentum band

Price vs 200-day MA

+58.1%

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

1.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AXGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AXGN stock rating?

Axogen, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AXGN analysis?

The full report lives at /stocks/AXGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AXGN?

The latest report frames AXGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AXGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.